Sign In
Buy AIMLF
$0.0385
+0.0003 (+0.785%)
At Close: Jun 03, 2026
AI/ML Subsidiary NeuralCloud Appoints Cardiac Monitoring Veterans Dale and Nicholas DuBois to Lead Clinical and Overread Operations
07:00am, Tuesday, 02'nd Jun 2026
Appointments bring more than 50 combined years of cardiac monitoring, ECG overread (the expert clinical review of ECG recordings by trained technicians and cardiologists), and regulatory validation ex
AI/ML Innovations Inc. Announces Closing of Final Tranche of Private Placement to Raise $1,917,500
10:20pm, Monday, 11'th May 2026
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / May 11, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE
AIML Appoints Dr. Martin Green to Medical Advisory Board and Issue Options
07:00am, Monday, 11'th May 2026
Founding Architect of Canadian Cardiac Electrophysiology and 45-Year Authority on Electrocardiography Joins AIML's Medical Advisory Board TORONTO, ON / ACCESS Newswire / May 11, 2026 / AI/ML Innovatio
AI/ML Innovations Announces Completion of Share Issuance
07:51pm, Friday, 24'th Apr 2026
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / April 24, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (C
AI/ML Innovations Announces Completion of Share Issuance
08:00pm, Friday, 17'th Apr 2026
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / April 17, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (C
Neural Cloud Signs Reseller Agreement with European Digital Cardiac Monitoring Platform
07:00am, Tuesday, 31'st Mar 2026
Collaboration Expands Reach of MaxYield™ into Remote Heart Monitoring and Preventive Cardiology Applications TORONTO, ON / ACCESS Newswire / March 31, 2026 / AI/ML Innovations Inc. ("AIML" or the "C
AI/ML Innovations Inc. Announces Closing of First Tranche of Private Placement to Raise $950,000
05:00pm, Friday, 27'th Mar 2026
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / March 27, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (C
AIML Subsidiary NeuralCloud Enters Research Services Agreement with Baker Heart and Diabetes Institute to Support AI-Driven ECG Analysis
07:00am, Wednesday, 25'th Mar 2026
Agreement expands NeuralCloud's role in cardiovascular research and academic collaborations MaxYield™ platform to support heart rate variability analysis in post-exertional malaise research TORONTO,
AI/ML Innovations Inc. Announces Proposed Private Placement of Convertible Debentures
07:30pm, Thursday, 12'th Mar 2026
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES OF AMERICA TORONTO, ON / ACCESS Newswire / March 12, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (C
Neural Cloud Enters Distribution Agreement with Intelimed to Expand into Latin America
07:30am, Tuesday, 24'th Feb 2026
Intelimed Appointed Exclusive Distributor in Chile and Non-Exclusive Distributor Across Latin America to lead commercialization in the region TORONTO, ON / ACCESS Newswire / February 24, 2026 / AI/ML
AIML Subsidiary NeuralCloud Signs Non-Binding Agreement with Movesense to Pilot AI-Powered ECG and Holter Reporting
07:00am, Thursday, 12'th Feb 2026
Collaboration enables deployment of MaxYield™ and CardioYield™ into third-party health systems and clinic sites This pilot expands the Movesense collaboration to scale low-cost, AI-powered 1-lead
Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion
07:00am, Tuesday, 10'th Feb 2026
Engagement Supports Commercial Readiness Strategy for MaxYield™ and CardioYield™ in the United States TORONTO, ON / ACCESS Newswire / February 10, 2026 / AI/ML Innovations Inc. ("AIML" or the "Com
AIML Appoints Dr. Paul Dorian as Medical Innovation Architect and Head of the Medical Advisory Board
07:00am, Wednesday, 28'th Jan 2026
World Renowned Cardiologist and Research Leader to Guide Clinical Strategy, Product Innovation, and AI-Driven Cardiac Diagnostics TORONTO, ON / ACCESS Newswire / January 28, 2026 / AI/ML Innovations I
AIML Subsidiary NeuralCloud Collaborates with Movesense to Expand Bundled ECG Solutions for Clinical and Wellness Markets
07:30am, Tuesday, 20'th Jan 2026
Collaboration enables integrated device-plus-AI offerings supporting scalable ECG analysis, visualization, and report generation Combination of single-lead wearable devices and AI algorithms creating
Agreement positions NeuralCloud's AI-driven cardiac platform for Holter monitoring and ambulatory patient workflow. Partnership introduces CardioYield™ powered by MaxYield™ for automated, reliable
